Hillstream BioPharma, Inc.
HILS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $235 | $236 | $4,381 | $35,828 |
| - Cash | $3,559 | $10,935 | $6,511 | $4 |
| + Debt | $0 | $0 | $0 | $2,165 |
| Enterprise Value | -$3,325 | -$10,699 | -$2,130 | $37,989 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12,434 | -$9,455 | -$6,882 | $457 |
| % Margin | – | – | – | – |
| Net Income | -$12,198 | -$9,319 | -$8,473 | -$3,038 |
| % Margin | – | – | – | – |
| EPS Diluted | -9.41 | -7.14 | -0.75 | -0.3 |
| % Growth | -31.8% | -852% | -150% | – |
| Operating Cash Flow | -$10,902 | -$7,300 | -$6,558 | -$1,086 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$10,902 | -$7,300 | -$6,558 | -$1,086 |